Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;147(1):111-115.e1.
doi: 10.1016/j.ajo.2008.07.041. Epub 2008 Oct 2.

Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin

Affiliations

Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin

Saloni Walia et al. Am J Ophthalmol. 2009 Jan.

Abstract

Purpose: To determine if a positive response of macular cysts to treatment with dorzolamide eye drops in patients with juvenile X-linked retinoschisis (XLRS) can occur with mutations that result in different types of retinoschisin protein dysfunction.

Design: Retrospective case series.

Methods: Thirteen eyes of seven patients seen at the University of Illinois at Chicago with a known diagnosis of XLRS were included. Each patient had received or currently was receiving treatment with topical dorzolamide. One patient from each family was screened for a genetic mutation. Using the method of cell transfection and protein preparation, the mutation in each patient was analyzed further and was categorized into one of three groups: 1) total absence of retinoschisin protein secretion, 2) decreased expression of the secreted protein, or 3) secretion of a nonfunctional protein. The response to dorzolamide was observed using optical coherence tomography.

Results: Significant improvement in the foveal zone thickness was observed with the use of dorzolamide in three of four patients with absence of protein secretion, in two patients with a lack of protein expression, and in one patient with a nonfunctional protein secretion.

Conclusions: This study showed that the response of macular cysts to dorzolamide in patients with XLRS may be observed independent of the mechanism responsible for retinoschisin protein dysfunction. Hence, treatment with dorzolamide may be effective in patients with different mechanisms of dysfunction in retinoschisin.

Trial registration: ClinicalTrials.gov NCT00716586.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Expression and secretion of wild-type (WT) and G70S (Gly70Ser) mutant retinoschisin. Cells expressing WT or mutant retinoschisin were separated into the cellular (cells) and secreted fraction (medium). The expressed proteins were run on 10% SDS–polyacrylamide gels under reducing conditions. Western blots were labeled with the RS1 3R10 monoclonal antibody. In contrast to WT retinoschisin, the G70S mutant was not present in the secreted fraction

References

    1. Forsius H, Krause U, Helve J, et al. Visual acuity in 183 cases of X-chromosomal retinoschisis. Can J Ophthalmol. 1973;8:385–393. - PubMed
    1. Sieving PA, Yashar BM, Ayyagari R. Juvenile retinoschisis: a model for molecular diagnostic testing of X-linked ophthalmic disease. Trans Am Ophthalmol Soc. 1999;97:451–464. - PMC - PubMed
    1. Gao H, Kusumi R, Yung CW. Optical coherence tomographic findings in X-linked juvenile retinoschisis. Arch Ophthalmol. 2005;123:1006–1008. - PubMed
    1. Apushkin MA, Fishman GA, Janowicz MJ. Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis. Ophthalmology. 2005;112:495–501. - PubMed
    1. Deutman AF. Sex-linked juvenile retinoschisis. In: Deutman AF, editor. The hereditary dystrophies of the posterior pole of the eye. Assen, the Netherlands: Van Gorcum; 1971. pp. 48–98.

Publication types

MeSH terms

Associated data